Protein A Resin is a technique for the separation and purification of classes and subclasses of fragmented protein from biological fluids like blood, plasma, urine, etc. and monoclonal antibodies which are the laboratory-produced molecules to work as a substitute antibodies which can perform the function like restoration and enhance or mimic the immune system's attack on cancer cells.
- Increasing Prevalence of Cancer and Other Chronic Diseases
- Rising Research and Development Activities
- High Cost of Protein A Resin can be the Hindrance for the Market
- Complexities Involved with Production of Protein A Resin
The key Players profiled in the report are GE Healthcare (United States), Thermo Fisher Scientific (United States), Repligen Corporation (United States), Merck Millipore (United States), Tosoh Bioscience (Japan), Novasep Inc. (France), GenScript Biotech (United States), Expedeon (United Kingdom) and Purolite Corporation (United States).